Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. The company operates in two segments, Health Plans and Other. As of December 31, 2020, it served approximately 4.0 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 15 states. The company offers its health care services for its members through contracts with a network of providers, including independent physicians and physician groups, hospitals, ancillary providers, and pharmacies. Molina Healthcare, Inc. was founded in 1980 and is headquartered in Long Beach, California.
IPO Year: 2003
Exchange: NYSE
Website: molinahealthcare.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/22/2025 | $414.00 | Outperform | Bernstein |
| 4/15/2025 | $375.00 | Outperform → Neutral | Robert W. Baird |
| 3/5/2025 | $295.00 → $372.00 | Equal Weight → Overweight | Wells Fargo |
| 12/17/2024 | $378.00 → $350.00 | Neutral | Analyst |
| 5/30/2024 | $405.00 | Outperform | Robert W. Baird |
| 3/28/2024 | $439.00 | Neutral → Underperform | BofA Securities |
| 3/6/2024 | $437.00 | Equal Weight | Barclays |
| 2/15/2024 | $367.00 → $420.00 | Underweight → Equal Weight | Wells Fargo |
| 6/20/2023 | $310.00 | Neutral | UBS |
| 4/21/2023 | $354.00 | Overweight | Cantor Fitzgerald |
Bernstein initiated coverage of Molina Healthcare with a rating of Outperform and set a new price target of $414.00
Robert W. Baird downgraded Molina Healthcare from Outperform to Neutral and set a new price target of $375.00
Wells Fargo upgraded Molina Healthcare from Equal Weight to Overweight and set a new price target of $372.00 from $295.00 previously
Analyst resumed coverage of Molina Healthcare with a rating of Neutral and set a new price target of $350.00 from $378.00 previously
Robert W. Baird initiated coverage of Molina Healthcare with a rating of Outperform and set a new price target of $405.00
BofA Securities downgraded Molina Healthcare from Neutral to Underperform and set a new price target of $439.00
Barclays initiated coverage of Molina Healthcare with a rating of Equal Weight and set a new price target of $437.00
Wells Fargo upgraded Molina Healthcare from Underweight to Equal Weight and set a new price target of $420.00 from $367.00 previously
UBS initiated coverage of Molina Healthcare with a rating of Neutral and set a new price target of $310.00
Cantor Fitzgerald initiated coverage of Molina Healthcare with a rating of Overweight and set a new price target of $354.00
SCHEDULE 13G - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
S-8 - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
10-Q - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
DEFA14A - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
DEF 14A - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
SCHEDULE 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
3 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
Reaffirms Full Year 2025 Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported first quarter 2025 GAAP earnings per diluted share of $5.45 and adjusted earnings per diluted share of $6.08. Financial results are summarized below: Three months ended March 31, 2025 2024 (In millions, except per-share results) Premium Revenue $10,628 $9,504 Total Revenue $11,147 $9,931 GAAP: Net Income $298 $301 EPS – Diluted $5.45 $5.17 Medical Care Ratio (MCR) 89.2% 88.5% G&A Ratio 6.9% 7.2
Molina Healthcare, Inc. (NYSE:MOH) ("Molina" or the "Company") announced today that the Company's subsidiary, Molina Healthcare of Illinois, Inc., was one of four managed care organizations awarded a contract by the Illinois Department of Healthcare and Family Services to provide a Fully Integrated Dual Eligible Special Needs Plan (D-SNP). This contract will replace the State's Medicare-Medicaid Alignment Initiative (MMAI) demonstration program, which currently serves approximately 73,000 beneficiaries. The go-live date for the new contract is expected to be January 1, 2026. The contract is expected to have an initial term of four years, with the option to extend the contract from the init
Molina Healthcare, Inc. (NYSE:MOH) today announced it will issue its earnings release for the first quarter ending March 31, 2025, after the market closes on Wednesday, April 23, 2025, and will host a conference call and webcast to discuss the earnings release on Thursday, April 24, 2025, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 3317326. A telephonic replay of the conference call will be available through Thursday, May 1, 2025, by dialing (877) 344-7529 and entering the confirmation number, 6106565. A live broadcast of Molina Healthcare's conference call will be available on the Company's investor relations
Introduces Full Year 2025 Revenue and Earnings Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported fourth quarter 2024 GAAP earnings per diluted share of $4.44 and adjusted earnings per diluted share of $5.05. The Company also reported full year 2024 GAAP earnings per diluted share of $20.42 and adjusted earnings per diluted share of $22.65. Financial results are summarized below: Three months ended Year ended December 31, December 31, 2024 2023 2024 2023 (In millions, except per-s
Molina Healthcare, Inc. (NYSE:MOH) today announced that its acquisition of ConnectiCare Holding Company, Inc. ("ConnectiCare") closed effective as of February 1, 2025. At closing, ConnectiCare served approximately 140,000 members across Marketplace, Medicare, and certain commercial products. About Molina Healthcare Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. For more information about Molina Healthcare, please visit MolinaHealthcare.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20250203763077/en/ Investor Contact: Jeffrey
Molina Healthcare, Inc. (NYSE:MOH) today announced it will issue its earnings release for the fourth quarter and year ending December 31, 2024, after the market closes on Wednesday, February 5, 2025, and will host a conference call and webcast to discuss the earnings release on Thursday, February 6, 2025, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 6464707. A telephonic replay of the conference call will be available through Thursday, February 13, 2025, by dialing (877) 344-7529 and entering the confirmation number, 2353454. A live broadcast of Molina Healthcare's conference call will be available on the Comp
Molina Healthcare, Inc. (NYSE:MOH) ("Molina" or the "Company") announced today that the Michigan Department of Health and Human Services (MDHHS) has awarded a contract to Molina's health plan subsidiary, Molina Healthcare of Michigan, to provide a Highly Integrated Dual Eligible Special Needs Plan (HIDE SNP). This new award follows the initial notice of intent to award the HIDE SNP contract announced by the MDHHS on October 9, 2024, and subsequently cancelled on November 8, 2024. The new benefit plan, MI Coordinated Health, will be available to individuals enrolled in both Medicare and Medicaid. Molina confirmed it was awarded the contract in eleven service regions – Michigan's entire lower
Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today announced the closing of its previously announced offering of $750 million aggregate principal amount of 6.250% senior notes due 2033 (the "Notes") sold in a private offering to individuals reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to certain persons outside the United States in reliance on Regulation S under the Securities Act. The Notes bear interest at a rate of 6.250% per annum. Interest on the Notes is payable semi-annually in arrears on January 15 and July 15 of each year, commencing July 15, 2025, and accrues from N
Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today announced that it priced $750 million aggregate principal amount of its 6.250% senior notes due 2033 (the "Notes") to be sold in a private offering to individuals reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to certain persons outside the United States in reliance on Regulation S under the Securities Act. The offering is expected to close on or about November 18, 2024 (such actual closing date, the "Settlement Date"), subject to the satisfaction of customary closing conditions. The Notes will not be guaranteed by any of the C
Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today announced that it intends to privately offer, subject to market and other conditions, $500 million aggregate principal amount of senior notes due 2033 (the "Notes"). The Company will make the offering pursuant to an exemption under the Securities Act of 1933, as amended (the "Securities Act"). The initial purchasers will sell the Notes only to persons reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act and to certain persons outside the United States in reliance on Regulation S under the Securities Act ("Regulation S"). The Notes will not be guaranteed by any of the Company's sub
Reaffirms Full Year 2025 Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported first quarter 2025 GAAP earnings per diluted share of $5.45 and adjusted earnings per diluted share of $6.08. Financial results are summarized below: Three months ended March 31, 2025 2024 (In millions, except per-share results) Premium Revenue $10,628 $9,504 Total Revenue $11,147 $9,931 GAAP: Net Income $298 $301 EPS – Diluted $5.45 $5.17 Medical Care Ratio (MCR) 89.2% 88.5% G&A Ratio 6.9% 7.2
Molina Healthcare, Inc. (NYSE:MOH) today announced it will issue its earnings release for the first quarter ending March 31, 2025, after the market closes on Wednesday, April 23, 2025, and will host a conference call and webcast to discuss the earnings release on Thursday, April 24, 2025, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 3317326. A telephonic replay of the conference call will be available through Thursday, May 1, 2025, by dialing (877) 344-7529 and entering the confirmation number, 6106565. A live broadcast of Molina Healthcare's conference call will be available on the Company's investor relations
Introduces Full Year 2025 Revenue and Earnings Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported fourth quarter 2024 GAAP earnings per diluted share of $4.44 and adjusted earnings per diluted share of $5.05. The Company also reported full year 2024 GAAP earnings per diluted share of $20.42 and adjusted earnings per diluted share of $22.65. Financial results are summarized below: Three months ended Year ended December 31, December 31, 2024 2023 2024 2023 (In millions, except per-s
Molina Healthcare, Inc. (NYSE:MOH) today announced it will issue its earnings release for the fourth quarter and year ending December 31, 2024, after the market closes on Wednesday, February 5, 2025, and will host a conference call and webcast to discuss the earnings release on Thursday, February 6, 2025, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 6464707. A telephonic replay of the conference call will be available through Thursday, February 13, 2025, by dialing (877) 344-7529 and entering the confirmation number, 2353454. A live broadcast of Molina Healthcare's conference call will be available on the Comp
Reaffirms Full Year 2024 Earnings Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported third quarter 2024 GAAP earnings per diluted share of $5.65 and adjusted earnings per diluted share of $6.01. Financial results are summarized below: Three months ended Nine months ended September 30, September 30, 2024 2023 2024 2023 (In millions, except per-share results) Premium Revenue $ 9,694 $ 8,240 $ 28,644 $ 24,167 Total Revenue $ 10,340 $ 8,548 $ 30,151
Molina Healthcare, Inc. (NYSE:MOH) ("Molina" or the "Company") today announced it will issue its earnings release for the third quarter ending September 30, 2024, after the market closes on Wednesday, October 23, 2024, and will host a conference call and webcast to discuss the earnings release on Thursday, October 24, 2024, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 7014206. A telephonic replay of the conference call will be available through Thursday, October 31, 2024, by dialing (877) 344-7529 and entering the confirmation number, 5232318. A live broadcast of Molina Healthcare's conference call will be avai
Reaffirms Full Year 2024 Earnings Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported second quarter 2024 GAAP earnings per diluted share of $5.17 and adjusted earnings per diluted share of $5.86. Financial results are summarized below: Three months ended Six months ended June 30, June 30, 2024 2023 2024 2023 (In millions, except per-share results) Premium Revenue $ 9,446 $ 8,042 $ 18,950
Molina Healthcare, Inc. (NYSE:MOH) today announced it will issue its earnings release for the second quarter ending June 30, 2024, after the market closes on Wednesday, July 24, 2024, and will host a conference call and webcast to discuss the earnings release on Thursday, July 25, 2024, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 8508329. A telephonic replay of the conference call will be available through Thursday, August 1, 2024, by dialing (877) 344-7529 and entering the confirmation number, 5266367. A live broadcast of Molina Healthcare's conference call will be available on the Company's website, molinah
Reaffirms Full Year 2024 Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported first quarter 2024 GAAP earnings per diluted share of $5.17 and adjusted earnings per diluted share of $5.73. Financial results are summarized below: Three months ended March 31, 2024 2023 (In millions, except per-share results) Premium Revenue $9,504 $7,885 Total Revenue $9,931 $8,149 GAAP: Net Income $301 $321 EPS – Diluted
Molina Healthcare, Inc. (NYSE:MOH) today announced details for the release of its results for the first quarter ending March 31, 2024. Molina Healthcare will issue its earnings release for the first quarter ending March 31, 2024, after the market closes on Wednesday, April 24, 2024, and will host a conference call and webcast to discuss the earnings release on Thursday, April 25, 2024, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 0974846. A telephonic replay of the conference call will be available through Thursday, May 9, 2024, by dialing (877) 344-7529 and entering the confirmation number, 7039934. A live